AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
U.S. Food and Drug Administration (FDA)-mandated testing of all donated blood for HIV-2 antibodies may be counterproductive, a U.S. Centers for Disease Control (CDC) study indicates.
Beginning June 1, 1992, the FDA will require all U.S. blood centers to test blood and plasma donations for antibodies to HIV-2 using newly licensed enzyme immunoassays (EIAs).
Data in an article by U.S. Centers for Disease Control researchers Thomas R. O'Brien and colleagues challenge the wisdom of this policy. The article, published in the May 27, 1992, issue of the Journal of the American Medical Association (1992;267:2775-9), stresses that HIV-2 is very …